Dr. Reddy's Laboratories Ltd.

Industry

  • Pharmaceuticals
    • Generic Drugs
    • Vaccines
    • OTC, Consumer
    • Specialty Pharmaceuticals
  • Biotechnology
  • Digital Health
    • Disease Management

Other Names/Subsidiaries

  • American Remedies and Development B.V.
  • Aurigene
  • Aurigene Discovery Technologies
  • Aurigene Oncology
  • Dr. Reddy’s Research
  • Dr. Reddy's Research and Development B.V.
  • Imperial Credit
  • Litaphar Laboratorios
  • OctoPlus N.V.
  • Promius Pharma
  • Wockhardt
See more in Biomedtracker

Latest on Dr. Reddy's Laboratories Ltd.

Scrip

Battle For Obesity Market Shifts Gears in India: Will Wegovy Trump Mounjaro?

 
• By Anju Ghangurde

Novo Nordisk’s Wegovy (injectable semaglutide) has made its India debut, setting the stage for a tight battle with rival Eli Lilly’s Mounjaro (tirzepatide) in a market where an estimated 254 million p

Generics Bulletin

Dr Reddy’s And Alvotech Team Up On Keytruda Rival

 
• By Dave Wallace

Dr Reddy’s and Alvotech have struck a further biosimilars alliance, announcing today a co-development partnership for a rival to Merck & Co/Merck Sharp & Dohme’s top-selling Keytruda (pembroli

Scrip

Public Health And Innovation: Addressing Gaps, Pharma’s Role

 
• By Anju Ghangurde

A high-profile expert panel that included renowned clinician-scientist and director of the Cancer Science Institute of Singapore, Prof Ashok Venkitaraman, discussed some of the pressing global public

Scrip

Asia Deal Watch: Lilly Partners With Rznomics On Hearing Loss

 
• By Joseph Haas, Xu Hu, Anju Ghangurde, and Lisa Takagi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Rznomics To Partner With Lilly On